Results 41 to 50 of about 31,414 (269)

Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta‐Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background In patients with suspected cardiac sarcoidosis, late gadolinium enhancement on cardiovascular magnetic resonance imaging and/or 18F‐fluorodeoxyglucose uptake on positron emission tomography are often used to reach a clinical diagnosis of ...
Osama Okasha, Felipe Kazmirczak, Ko‐Hsuan Amy Chen, Afshin Farzaneh‐Far, Chetan Shenoy   +4 more
doaj   +1 more source

PET-CMR in heart failure - synergistic or redundant imaging? [PDF]

, 2017
Imaging in heart failure (HF) provides data for diagnosis, prognosis and disease monitoring. Both MRI and nuclear imaging techniques have been successfully used for this purpose in HF.
Quail, MA, Sinusas, AJ
core   +1 more source

Histology of Cardiac Sarcoidosis with Novel Considerations Arranged upon a Pathologic Basis

Journal of Clinical Medicine, 2022
Sarcoidosis is a rare disease of isolated or diffuse granulomatous inflammation. Although any organs can be affected by sarcoidosis, cardiac sarcoidosis is a fatal disorder, and it is crucial to accurately diagnose it to prevent sudden death due to ...
S. Kato, Y. Sakai, Asako Okabe, Yoshiaki Kawashima, K. Kuwahara, K. Shiogama, M. Abe, Hiroyasu Ito, S. Morimoto   +8 more
semanticscholar   +1 more source

Infliximab Treatment of Refractory Cardiac Sarcoidosis

JACC: Case Reports, 2020
Treatment of cardiac sarcoidosis is challenging, as the disease can be refractory to traditional treatment with steroids. Infliximab, a tumor necrosis factor-α inhibitor, has been reportedly used in cardiac sarcoidosis, but published evidence is limited.
Majid Asawaeer, MD, Benjamin Widener, MD, Varda Singhal, MBBS, Matthew J. DeVries, MD, Debra J. Romberger, MD, Alan R. Erickson, MD, Yiannis S. Chatzizisis, MD, PhD   +6 more
doaj   +1 more source

Monomorphic Ventricular Arrhythmias in Athletes. [PDF]

, 2019
Ventricular arrhythmias are challenging to manage in athletes with concern for an elevated risk of sudden cardiac death (SCD) during sports competition. Monomorphic ventricular arrhythmias (MMVA), while often benign in athletes with a structurally normal
Aboulhosn, Jamil A, Boyle, Noel G, Bradfield, Jason S, Dave, Ravi H, Horwich, Tamara B, Hsu, Jeffrey J, Nsair, Ali, Shannon, Kevin M, Shivkumar, Kalyanam   +8 more
core   +2 more sources

Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection

ESC Heart Failure, 2022
Patients infected with SARS‐CoV‐2 have varying manifestations of cardiac involvement. We report four patients presenting with symptomatic cardiac sarcoidosis (CS) or giant cell myocarditis (GCM) 1–8 months after mild COVID‐19.
E. Bollano, CL Polte, M. Mäyränpää, A. Oldfors, N. Bergh, J. Lehtonen, R. Kandolin   +6 more
semanticscholar   +1 more source

Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis

EJNMMI Research, 2017
Background 18F-FDG PET has been used in sarcoidosis for diagnosis and determination of the extent of the disease. However, assessing inflammatory lesions in cardiac sarcoidosis using 18F-FDG can be challenging because it accumulates physiologically in ...
Takashi Norikane, Yuka Yamamoto, Yukito Maeda, Takahisa Noma, Hiroaki Dobashi, Yoshihiro Nishiyama   +5 more
doaj   +1 more source

Concurrent cardiac sarcoidosis and obstructive sleep apnea presenting as arrhythmias

BMC Pulmonary Medicine, 2020
Background Cardiac involvement is a rare and potentially fatal presentation of sarcoidosis. Obstructive sleep apnea may complicate sarcoidosis. Case presentation We report a case of a sarcoidosis patient with cardiac involvement presenting with ...
Foteini Malli, Fotini Bardaka, Konstantinos I. Gourgoulianis, Zoe Daniil   +3 more
doaj   +1 more source

Severe cardiogenic shock and cardiac arrest due to fulminant cardiac sarcoidosis: a case report

BMC Cardiovascular Disorders, 2023
Background Cardiac sarcoidosis is found to occur in approximately 5% of patients with sarcoidosis. Its presentation can typically range from complete heart block to ventricular arrhythmias.
Teja Chakrala, Roshni O. Prakash, Anshul Jain, R. Ashton Vautier, Sahil Prasada, Mohammed Al-Ani, Mustafa M. Ahmed   +6 more
doaj   +1 more source

Glucocorticoids for treating paediatric pulmonary hypertension: A novel use for a common medication [PDF]

, 2017
Laboratory investigations have shown the role of inflammation in the pathogenesis of pulmonary hypertension and improvement after anti-inflammatory drugs.
Aggarwal, Manish, Grady, Ronald M
core   +2 more sources